AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
RYET

Ruanyun Edai Technology Inc. Ordinary shares (RYET) fair value

Consumer Defensive · Education & Training Services · NASDAQ · United States
$0.70-1.56%
Market cap $27MUpdated Oct 24, 2026
Our verdict
Trades 105% above our fair value
Price
$0.70
Model fair valueConfidence: low
about $0.34
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Treated as a loss-making company. None of the usual models had enough data, so this uses Net asset value and Discounted cash flow instead.
ACCE opinionRuanyun Edai Technology Inc. Ordinary shares (RYET)
Fair value (2 models)
Not available
ACCE price target
$0.40
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $0.70 at the close on 23 Oct 2026, 22:00 CEST.
Models: Net asset value and Discounted cash flow.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
33
out of 100
P/E
0.0x
forward 0.0x
1-year return
-40.7%
Dividend yield
0.00%

Ruanyun Edai Technology Inc. Ordinary shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Ruanyun Edai Technology sells education and training services, and at a $31M market cap with 176% revenue growth, it sits in the small, high-growth, loss-making end of the sector. The 25% gross margin is thin for an education provider, and the -51% operating margin and -331% ROE say the company is still spending well ahead of what it earns, so growth is being bought rather than earned. The 0.0 P/E figures reflect negative earnings, which leaves valuation resting on revenue rather than profit. Its score of 33/100 and absence from any index mean the case has to be built from the filings, not from consensus or coverage. The question for a portfolio manager is whether that revenue growth is converting toward operating breakeven, and nothing in this data shows that yet.

AI-assisted·How I use AIWritten Oct 18, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where RYET's valuation models land
Price
$0.70
Model fair valueConfidence: low
about $0.34
Model
Fair value
Upside
Net asset value
Discounted cash flow
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-11.4%
1 month
-19.5%
3 months
-32.0%
6 months
-39.7%
YTD
-35.2%
1 year
-40.7%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$0.40first publication$0.88
8 Oct 2026, 00:00 CESTFair value$0.54first publication$0.98

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full RYET page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value15Quality35Momentum17Total33
Valuation
Trailing P/E
0.0x
Forward P/E
0.0x
PEG
no data
P/B
5.70x
EV / Revenue
4.3x
Book value/sh
$0.16
Enterprise value
$33M
Profitability
ROE
-331.4%
FCF yield
-34.73%
ROIC
-64.7%
Health and risk
Debt / equity
0.75
Dividend yield
0.00%
Beta
no data

Price

-39.1% · 1Y

Ask anything about RYET

Answered from Ruanyun Edai Technology Inc. Ordinary shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 5.6x
ROEbetter than 0% of peers
low -331%-331%high 35%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
RYET Ruanyun Edai Technology Inc. Ordinary shares$0.70----331.4%3533
FEDU Four Seasons Education (Cayman) Inc. American Depositary Shares each ADS representing 10 ordinary shares$10.48$117% below5.6x5.7%5754
YQ 17 Education & Technology Group Inc. American Depositary Shares$3.18----37.6%4765
STG Sunlands Technology Group American Depositary Shares representing Class A ordinary shares$2.44--0.7x34.9%9354
YOUL Youlife Group Inc. American Depositary Shares$0.27$042% below4.4x4.8%3447
JDZG JIADE LIMITED Class A Ordinary Shares$6.56----11.0%4340
AACG ATA Creativity Global American Depositary Shares$0.73----86.1%4335

Sector report card

Where RYET ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 9, 2026
    Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
  • GlobeNewswire•Oct 7, 2026
    BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
  • GlobeNewswire•Oct 5, 2026
    RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
22 more press releases · full archive on Investor+.INVESTOR
24 filings of 27
October 2026
Oct 9
6-KForeign current reportPeriod 2026-10-09
View on SEC →
Oct 2
6-KForeign current reportPeriod 2026-10-02
View on SEC →
September 2026
Sep 10
6-KForeign current reportPeriod 2026-09-10
View on SEC →
21 more filings + AI summaries on Investor+.INVESTOR